UTI Asset Management Company Ltd
UTIAMCUTI Asset Management Company Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is in a downtrend (34 weeks in) while the P/BV sits at the 19th percentile of its own 6-year range. Underneath, the last four quarters read improving — profit +15.7% year on year, with the the net margin at 50.3%. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
UTI Asset Management Company Ltd trades at ₹903, in a downtrend and 34 weeks into that stage. That is −12.0% against its own 200-day average. It sits at 4% of a 52-week range of ₹881 to ₹1,402. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (3 weeks and counting).
Today the stock is in a downtrend — week 34 of stage 4, confirmed. At ₹903 it trades −12.0% versus its 200-day average and sits at 4% of its 52-week range (₹881–₹1,402).
Against the market, two honest reads. Cumulative: over the last 5.8 years the stock moved +80% while the NIFTY 500 moved +140% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-07-10) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
UTI Asset Management Company Ltd trades at 2.6× P/BV, near the bottom of its own range — cheaper only 19% of the time. Its long-run median P/BV is 2.9×, measured across 5.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 2.6× is near the bottom of its own range — cheaper only 19% of the time, against a long-run median of 2.9× measured over 5.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 10% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
Why the multiple sits where it does: over the past year book value grew while the price moved −30.4% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the −2.8%/yr price move, ~+6.5%/yr came from book-value growth and ~−9.3 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 42% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
UTI Asset Management Company Ltd reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −35.3% latest against +63.6% at its 12-quarter best). The read is built from 8 quarters across 3 curves, on partial evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −7.9% | +10.4% | +7.8% | — |
| Profit | −41.9% | +2.4% | −0.9% | — |
| EPS | −45.0% | −3.0% | −4.2% | — |
| Share price | −30.4% | +4.8% | −2.8% | — |
4-Factor Sector Score
32.5/100 — rank 5 of 7 in Finance - AMC · 61% evidence confidence
UTI Asset Management Company Ltd scores 32.5 out of 100 against the 7 companies it is compared with in Finance - AMC, ranking 5. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 8.7 + 9.6 + 11.2 + 3 = 32.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
UTI Asset Management Company Ltd reported ₹584 Cr of income in the Jun 26 quarter, +6.8% year on year. That is the 3rd straight quarter of year-on-year growth. Over 14 years it has compounded at 9.1% a year. The last full year, FY26, came in at ₹1,705 Cr. The last four reported quarters add to ₹1,910 Cr.
FY26 revenue came in at ₹1,705 Cr (−7.9% on the year), capping 14 years at 9.1% compound. The latest quarter (Jun 26) printed ₹584 Cr, +6.8% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +3.0% growth against the decade's 9.1% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +1.6% over the last 4 quarters against +3.1%/yr over the last 8 — stabilising; TTM profit −35.3% vs −21.9%/yr — rolling over.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
UTI Asset Management Company Ltd's net margin is 50.3% in the Jun 26 quarter, +3.9 percentage points against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 27.7% to 46.2%. The current quarter is running above every full year in that window.
The latest quarter's net margin is 50.3%, +3.9 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 27.7%–46.2%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
UTI Asset Management Company Ltd earned ₹294 Cr of net profit in the Jun 26 quarter, +15.7% year on year. Full-year FY26 profit was ₹472 Cr. The 14-year compound rate is 8.7%. That is 50.3% of the quarter's revenue. The same quarter a year earlier earned ₹254 Cr. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹294 Cr, +15.7% year on year. On the full year, FY26 printed ₹472 Cr (−41.9%), and the 14-year compound rate is 8.7%.
Why profit moved: revenue contributed +6.8% and the margin +3.9 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit −51.2% vs revenue +3.0%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for UTI Asset Management Company Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
UTI Asset Management Company Ltd's revenue grew −7.9% in FY26 to ₹1,705 Cr, so the book is flat. The latest quarter ran +6.8% year on year. The net margin on that income is 50.3%, +3.9 percentage points against a year ago.
FY26 revenue was ₹1,705 Cr, −7.9% on the year, and the latest quarter ran +6.8% year on year. The net margin on that revenue is 50.3% this quarter (+3.9 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers usually rate a lender: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys.
A clean annual return-on-equity ladder is not held for UTI Asset Management Company Ltd. For an insurer especially the standard bank ratios are not the right lens, so this page does not force them onto the filings rather than estimating a series it cannot support.
We do not hold a clean annual return-on-equity series for UTI Asset Management Company Ltd — for an insurer especially, the standard bank ratios are not the right lens, so this page does not force them. The revenue, margin and ownership sections above and below are the reads we stand behind.
The quarterly return-on-equity and return-on-assets curves, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 42% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions cut 1.1 points of UTI Asset Management Company Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 59.6% of the company. Foreign institutions moved +0.6 points over the same window, to 6.9%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −1.1 points over 8 quarters to 59.6%; Foreign institutions: +0.6 points over 8 quarters to 6.9%.
🚨 Why the register moved: domestic institutions drove it (−1.1 points), absorbed on the other side by foreign institutions (+0.6 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
UTI Asset Management Company Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Nippon Life India Asset Management LtdNAM-INDIA | 61.1/100Mixed-positive evidence67% evidence | LEADER | 24.6/35 Income 23% · PAT 21.3% 52% evidence | 16.3/25 ROA — · ROE 34.5% · GNPA — 34% evidence | 0.2/20 P/BV 15.9× · P/BV÷ROE 0.46 100% evidence | 20.0/20 RS sector 15.7% · RS bench 21.3% · 1Y 43.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 16.3 + 0.2 + 20 = 61.1 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Canara Robeco Asset Management Company LtdCRAMC | 52.1/100Mixed-positive evidence62% evidence | TURNING | 11.9/35 Income 13% · PAT 9% 86% evidence | 19.1/25 ROA 24.9% · ROE 30.3% · GNPA — 72% evidence | 11.1/20 P/BV 6.98× · P/BV÷ROE 0.23 70% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence |
| Exact sum: 11.9 + 19.1 + 11.1 + 10 = 52.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Aditya Birla Sun Life AMC LtdABSLAMC | 43.7/100Mixed-negative evidence67% evidence | FADING | 12.4/35 Income 6.6% · PAT 3.7% 52% evidence | 13.7/25 ROA — · ROE 25.2% · GNPA — 34% evidence | 3.9/20 P/BV 7.23× · P/BV÷ROE 0.29 100% evidence | 13.7/20 RS sector 4.6% · RS bench 9.5% · 1Y 18.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 12.4 + 13.7 + 3.9 + 13.7 = 43.7 · Decision use: Price leads the evidence: RS versus the benchmark is 9.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4HDFC Asset Management Company LtdHDFCAMC | 42.5/100Mixed-negative evidence61% evidence | ASLEEP | 20.7/35 Income 15.3% · PAT 13.2% 52% evidence | 15.4/25 ROA — · ROE 32.9% · GNPA — 34% evidence | 4.4/20 P/BV 12.17× · P/BV÷ROE 0.37 70% evidence | 2.0/20 RS sector -8.5% · RS bench -3.6% · 1Y -5.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 15.4 + 4.4 + 2 = 42.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5UTI Asset Management Company Ltdthis pageUTIAMC | 32.5/100Adverse evidence61% evidence | ASLEEP | 8.7/35 Income 1.6% · PAT -35.3% 52% evidence | 9.6/25 ROA — · ROE 10.3% · GNPA — 34% evidence | 11.2/20 P/BV 2.58× · P/BV÷ROE 0.25 100% evidence | 3.0/20 RS sector -19% · RS bench -18.6% · 1Y -33.4%0 of 10 weeks ahead 70% evidence |
| Exact sum: 8.7 + 9.6 + 11.2 + 3 = 32.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Tata Capital LtdTATACAP | 52.0/100Thin evidence · provisional44% evidence | TURNING | 21.7/35 Income 11.1% · PAT 29.7% 62% evidence | 11.7/25 ROA — · ROE 12.4% · GNPA — 34% evidence | 8.6/20 P/BV 3.38× · P/BV÷ROE 0.27 70% evidence | 10.0/20 RS sector — · RS bench — · 1Y —2 of 10 weeks ahead 0% evidence |
| Exact sum: 21.7 + 11.7 + 8.6 + 10 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7ICICI Prudential Asset Management Co LtdICICIAMC | 50.3/100Thin evidence · provisional1% evidence | ASLEEP | 17.5/35 Income — · PAT — 0% evidence | 12.8/25 ROA — · ROE — · GNPA — 6% evidence | 10.0/20 P/BV — · P/BV÷ROE — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —5 of 12 weeks ahead 0% evidence |
| Exact sum: 17.5 + 12.8 + 10 + 10 = 50.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is UTI Asset Management Company Ltd's share price today?
UTI Asset Management Company Ltd trades at ₹903, −30.4% over the past year. The company is valued at ₹11,607 Cr. The stock sits at 4% of its 52-week range of ₹881–₹1,402, −12.0% versus its 200-day average. On the tape, the price is in a downtrend, 34 weeks in. — as of 31 July 2026.
What were UTI Asset Management Company Ltd's latest quarterly results?
UTI Asset Management Company Ltd reported total income of ₹584 Cr and net profit of ₹294 Cr for the Jun 26 quarter. Income rose 6.8% and profit rose 15.7% year on year. Earnings per share were ₹22.86. The net margin was 50.3%, 3.9 pp higher than a year earlier. — as of 31 July 2026.
What is UTI Asset Management Company Ltd's revenue?
UTI Asset Management Company Ltd reported revenue of ₹584 Cr in the Jun 26 quarter, +6.8% year on year. For the full FY26 fiscal year, revenue was ₹1,705 Cr (−7.9%). Over the last 14 years revenue compounded at 9.1% a year. — as of 31 July 2026.
What is UTI Asset Management Company Ltd's profit?
UTI Asset Management Company Ltd earned ₹294 Cr of net profit in the Jun 26 quarter, +15.7% year on year. Full-year FY26 profit was ₹472 Cr. The net margin ran 50.3% in the latest quarter. — as of 31 July 2026.
What is UTI Asset Management Company Ltd's market cap?
UTI Asset Management Company Ltd's market capitalisation is ₹11,607 Cr at a share price of ₹903. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is UTI Asset Management Company Ltd's P/BV ratio?
UTI Asset Management Company Ltd trades at a P/BV of 2.6×, at the 19th percentile of its own 6-year range, against a long-run median of 2.9×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does UTI Asset Management Company Ltd pay a dividend?
Yes — UTI Asset Management Company Ltd's dividend payout was 127% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is UTI Asset Management Company Ltd overvalued?
On its own history, UTI Asset Management Company Ltd looks cheap against its own history: its P/BV of 2.6× has been cheaper only 19% of the time in 6 years (long-run median 2.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is UTI Asset Management Company Ltd growing?
Yes — UTI Asset Management Company Ltd is growing: latest-quarter revenue +6.8% year on year, profit +15.7%, and the the net margin +3.9 pp at 50.3%. The 14-year compound rates are 9.1% (revenue) and 8.7% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is UTI Asset Management Company Ltd performing?
UTI Asset Management Company Ltd is in a downtrend, 34 weeks in. Its latest quarter's income rose 6.8% and profit rose 15.7% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is UTI Asset Management Company Ltd in?
Deteriorating — profit and EPS growth are shrinking (profit growth −35.3% latest against +63.6% at its 12-quarter best). The read comes from the last 12 quarters of growth (revenue growth +1.6% latest, profit growth −35.3% latest, eps growth −35.8% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is UTI Asset Management Company Ltd in an uptrend?
No — the price is in a downtrend (week 34 of stage 4), trading −12.0% versus its 200-day average and at 4% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is UTI Asset Management Company Ltd beating the market?
Not lately — on a trailing-13-week view UTI Asset Management Company Ltd is currently behind the NIFTY 500 (3 weeks and counting; last ahead the week of 2026-07-10), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 5.8 years the stock moved +80% against the NIFTY 500's +140% — behind the index over the full window. — as of 31 July 2026.
Will UTI Asset Management Company Ltd's share price go up?
This page publishes no price forecast for UTI Asset Management Company Ltd. What it measures instead: the share price is ₹903, the price is in a downtrend 34 weeks in. Its P/BV of 2.6× sits at the 19th percentile of its own 6-year range. — as of 31 July 2026.
Is UTI Asset Management Company Ltd's loan book healthy?
We do not hold quarterly loan-book quality numbers for UTI Asset Management Company Ltd, so this page says that plainly. The cleanest available reads are revenue growth (−7.9% in FY26) and the net margin on it (50.3%) — as of 31 July 2026.
Where is UTI Asset Management Company Ltd in its business cycle?
UTI Asset Management Company Ltd's FY26 net margin was 27.7%, against a 13-year band of 27.7%–46.2%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 50.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the UTI Asset Management Company Ltd story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is UTI Asset Management Company Ltd a stock worth studying right now?
This is not investment advice. The machine read: UTI Asset Management Company Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.